Clinical Database and Biobank of Patients With Gynecologic Neoplasms

Sponsor

Huazhong University of Science and Technology (Other)

Overall Status

Unknown status

CT.gov ID

NCT01267851

Collaborator

Zhejiang University (Other), Hunan Province Tumor Hospital (Other), Guangxi Medical University (Other), First Affiliated Hospital Xi'an Jiaotong University (Other), West China Second University Hospital (Other), Obstetrics & Gynecology Hospital of Fudan University (Other), Shanghai First Maternity and Infant Hospital (Other), Peking University People's Hospital (Other), Wuhan Central Hospital (Other)

1,600,000

Enrollment

Location

131.9

Anticipated Duration (Months)

12126.5

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The database and biobank establishment started in 1997 in our institute. However, the sample size was too small with respect to our clinical and fundamental scientific research's requirement. Thus the Chinese gynecological oncology study (GOS) group was established to create a large multicentre database and biobank of patients with gynecologic diseases.

Condition or Disease	Intervention/Treatment	Phase
Cervical Cancer Ovarian Cancer Endometrial Cancer Choriocarcinoma Uterine Myoma Endometriosis

Detailed Description

The database contains clinical and epidemiologic information about patients with gynecologic neoplasms, such as cervical carcinoma, ovarian carcinoma, etc. With the data gathered from this database, the investigators could further demonstrate the etiology, risk factor, clinical treatment, and other aspects of the complicated gynecologic diseases. The cervical cancer database v1.10 including more than 10,000 cases and more than 200 variables has been established.

The biobank collects blood, fluids, tissue samples, and related clinical data from consenting patients with gynecologic neoplasms, such as cervical cancer, ovarian cancer, endometrial cancer, choriocarcinoma, uterine myoma, endometriosis. Besides, blood samples of population-based healthy people with informed consent are also collected.

Study Design

Study Type:

Observational

Anticipated Enrollment :

1600000 participants

Observational Model:

Other

Time Perspective:

Retrospective

Official Title:

A Large Multicentre Clinical Database and Biobank of Patients With Gynecologic Neoplasms

Actual Study Start Date :

Jan 1, 2010

Anticipated Primary Completion Date :

Dec 30, 2019

Anticipated Study Completion Date :

Dec 30, 2020

Outcome Measures

Primary Outcome Measures

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 75 Years

Sexes Eligible for Study:

Female

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

patients with informed consent;
patients with gynecologic diseases;
patients with intact clinical and pathological information

Exclusion Criteria:

not included in the inclusion criteria

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Tongji Hospital of HUST	Wuhan	Hubei	China

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Ding Ma, Director of the department of Obstetrics and Gynecology, Tongji Hospital, Huazhong University of Science and Technology

ClinicalTrials.gov Identifier:

NCT01267851

Other Study ID Numbers:

GM2010-06-02

First Posted:

Dec 29, 2010

Last Update Posted:

Jul 19, 2019

Last Verified:

Jul 1, 2019

Keywords provided by Ding Ma, Director of the department of Obstetrics and Gynecology, Tongji Hospital, Huazhong University of Science and Technology

gynecologic disease

Additional relevant MeSH terms:

Neoplasms

Endometrial Neoplasms

Choriocarcinoma

Leiomyoma

Myofibroma

Genital Neoplasms, Female

Endometriosis

Study Results

No Results Posted as of Jul 19, 2019